Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

BACKGROUND: The aim of the Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis Patients Who Have Achieved a Stable Low Disease Activity-State study was to investigate the effect of etanercept (ETN) dose maintenance, reduction or withdrawal on patients with rh...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Rheum Dis
Hlavní autoři: van Vollenhoven, Ronald F, Østergaard, Mikkel, Leirisalo-Repo, Marjatta, Uhlig, Till, Jansson, Marita, Larsson, Esbjörn, Brock, Fiona, Franck-Larsson, Karin
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2016
Témata:
Clinical and Epidemiological Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717401/
https://ncbi.nlm.nih.gov/pubmed/25873634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2014-205726
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky